Letter to the Editor Regarding “Diagnostic Considerations for COVID-19 in Recipients of Allogeneic Hematopoietic Cell Transplantation”
Biology of Blood and Marrow Transplantation(2020)
摘要
SARS-CoV-2 in hematopoietic cell transplant (HCT) recipients is associated with severe coronavirus disease-2019 (COVID-19) and higher mortality. SARS-CoV-2 infection is definitively diagnosed by real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) typically using nasopharyngeal (NP) swabs, and less commonly, samples from the lower respiratory tract, including bronchoalveolar lavage (BAL). In highly prevalent regions, stepwise evaluation, and management, as in the pre-COVID era, risks false-negatives and delay in therapy for COVID-19.
更多查看译文
关键词
allogeneic hematopoietic cell transplantation”
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要